Accendra Health secures $1.5B refinancing as Q1 results meet targets

Accendra Health (NYSE:ACH) reported first-quarter 2026 results that met internal expectations as the company nears the finish line of its transformation into a specialized home-based care provider.

Concurrent with the earnings, the Richmond-based company announced it has secured commitments from existing creditors for a $1.5 billion transaction aimed at eliminating 2027 maturities and significantly reducing total debt.

The capital restructuring includes a multi-year extension of the company’s revolving credit facility and a meaningful reduction in total leverage.

CEO Edward A. Pesicka stated the deal provides the "strategic and financial flexibility" necessary to operate as a pure-play entity following the divestiture of its global products division.

For the quarter ended March 31, 2026, Accendra reported net revenue of $627.8 million from continuing operations.

Adjusted EBITDA came in at $58.4 million, reflecting stable demand in its Apria and Byram healthcare brands.

Net loss for the quarter was recorded at $6.5 million ($0.08 per share), while adjusted net loss sat at $3.1 million.